These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 13107689)

  • 21. Eosinophilia and eosinophil helminthotoxicity in patients treated for Schistosoma mansoni infections.
    Kimani G; Chunge CN; Butterworth AE; Kamau T; Bwayo J; Gachihi G; Mungai B; Mugambi M
    Trans R Soc Trop Med Hyg; 1991; 85(4):489-92. PubMed ID: 1755057
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Mechanism of eosinopenia-inducing action of adrenalin in rat].
    PEIXOTO RI; FERREIRA JD
    C R Seances Soc Biol Fil; 1955 Oct; 149(19-20):1842-7. PubMed ID: 13317225
    [No Abstract]   [Full Text] [Related]  

  • 23. Interleukin 5 is required for the blood and tissue eosinophilia but not granuloma formation induced by infection with Schistosoma mansoni.
    Sher A; Coffman RL; Hieny S; Scott P; Cheever AW
    Proc Natl Acad Sci U S A; 1990 Jan; 87(1):61-5. PubMed ID: 2104985
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Comparative distribution of eosinophils in bone marrow, blood and peritoneal cavity in murine schistosomiasis.
    Lenzi HL; Lenzi JA
    Braz J Med Biol Res; 1990; 23(10):989-94. PubMed ID: 2129262
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Evidence that the glomerular zone is stimulated by epinephrine, causing an eosinopenia in hypophysectomized rats.
    MILLER RA; DOCKRELL AW
    Endocrinology; 1956 May; 58(5):550-6. PubMed ID: 13317829
    [No Abstract]   [Full Text] [Related]  

  • 26. Eosinophil activation status, cytokines and liver fibrosis in Schistosoma mansoni infected patients.
    Silveira-Lemos D; Teixeira-Carvalho A; Martins-Filho OA; Alves Oliveira LF; Costa-Silva MF; Matoso LF; de Souza LJ; Gazzinelli A; Corrêa-Oliveira R
    Acta Trop; 2008; 108(2-3):150-9. PubMed ID: 18550021
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A role for the eosinophil in acquired resistance to Schistosoma mansoni infection as determined by antieosinophil serum.
    Mahmoud AA; Warren KS; Peters PA
    J Exp Med; 1975 Oct; 142(4):805-13. PubMed ID: 1185104
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Comparison of epinephrine and ACTH action on the circulating eosinophils of mice.
    SPEIRS RS; SULLIVAN J
    Am J Physiol; 1953 May; 173(2):282-6. PubMed ID: 13065441
    [No Abstract]   [Full Text] [Related]  

  • 29. Studies on the endocrine regulation of the number of circulating eosinophil cells in the rat.
    JAKOBSON T; HORTLING H
    Acta Endocrinol (Copenh); 1954 Mar; 15(3):265-81. PubMed ID: 13147718
    [No Abstract]   [Full Text] [Related]  

  • 30. Study of eosinophilia in relation to serum IgE level and cell mediated immunity (CMI) to soluble egg antigen (SEA) in human schistosomiasis mansoni.
    Khalil SH; Khalil H; Fahmy MH; Said M; el Sawy M; Nofal M; Amara F; Taky M; Brock J; Arab M
    Allerg Immunol (Leipz); 1985; 31(2):105-8. PubMed ID: 3161309
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The ecology of eosinophils in schistosomiasis.
    Mahmoud AA
    J Infect Dis; 1982 May; 145(5):613-22. PubMed ID: 7042854
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The diurnal variation of blood leucocytes in normal and adrenalectomized mice.
    BROWN HE; DOUGHERTY TF
    Endocrinology; 1956 Mar; 58(3):365-75. PubMed ID: 13294085
    [No Abstract]   [Full Text] [Related]  

  • 33. Host and parasite determinants of morbidity in Egyptian children with schistosomiasis.
    Hussein HM; Kaddah MA; el-Borai YA; el Batanony GA; Abdel Ghafar FA; Zakaria S
    J Egypt Soc Parasitol; 1996 Dec; 26(3):755-72. PubMed ID: 8918048
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Enhanced helminthotoxic capacity of eosinophils from patients with eosinophilia.
    David JR; Vadas MA; Butterworth AE; de Brito PA; Carvalho EM; David RA; Bina JC; Andrade ZA
    N Engl J Med; 1980 Nov; 303(20):1147-52. PubMed ID: 7421931
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The presence of eosinophil-activating mediators in sera from individuals with Schistosoma mansoni infections.
    Mazza G; Thorne KJ; Richardson BA; Butterworth AE
    Eur J Immunol; 1991 Apr; 21(4):901-5. PubMed ID: 1902178
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Schistosoma mansoni infection and socio-behavioural predictors of HIV risk: a cross-sectional study in women from Uganda.
    Yegorov S; Galiwango RM; Good SV; Mpendo J; Tannich E; Boggild AK; Kiwanuka N; Bagaya BS; Kaul R
    BMC Infect Dis; 2018 Nov; 18(1):586. PubMed ID: 30453907
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Functional studies on purified eosinophils and neutrophils from patients with Schistosoma mansoni infections.
    Vadas MA; David JR; Butterworth AE; Houba V; Sturrock RF; David L; Herson R; Siongok TA; Kimani R
    Clin Exp Immunol; 1980 Mar; 39(3):683-94. PubMed ID: 7379332
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Ovaries and adrenals in murine Schistosomiasis mansoni. III. Morphology and function of the adrenals in acute infection.
    Tiboldi T; De Semet M; Colfs B; Van Soom H
    Am J Trop Med Hyg; 1979 Sep; 28(5):873-5. PubMed ID: 484769
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Purinergic P2Y12 Receptor Activation in Eosinophils and the Schistosomal Host Response.
    Muniz VS; Baptista-Dos-Reis R; Benjamim CF; Mata-Santos HA; Pyrrho AS; Strauch MA; Melo PA; Vicentino AR; Silva-Paiva J; Bandeira-Melo C; Weller PF; Figueiredo RT; Neves JS
    PLoS One; 2015; 10(10):e0139805. PubMed ID: 26448282
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Eosinophil-mediated destruction of Schistosoma mansoni eggs III. lymphokine involvement in the induction of eosinophil functional abilities.
    James SL; Colley DG
    Cell Immunol; 1978 Jun; 38(1):48-58. PubMed ID: 566624
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.